Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. Image source: . Pfizer has a ...

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

The drugmaker's stock has dropped by 15.91% in the past month, falling short of the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%. The investment community will be paying close ...

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Nueva York, 29 abr (.).- La farmacéutica estadounidense Pfizer (NYSE:PFE) anunció este martes un beneficio neto de 2.967 millones de dólares en el primer trimestre de 2025, un 5 % menos que en ...

In the latest trading session, Pfizer (PFE) closed at $22.15 ... these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this ...